» Articles » PMID: 30613926

Influence of Treatment Caused Impairments on Anxiety and Depression in Patients with Cancer of the Esophagus or the Esophagogastric Junction

Overview
Publisher Springer
Date 2019 Jan 8
PMID 30613926
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: After therapy of cancer of the esophagus or the esophagogastric junction, patients often suffer from anxiety and depression. Some risk factors for elevated anxiety and depression are reported, but the influence of steatorrhea, the frequency of which has only recently been reported, has not yet been investigated.

Method: Using the Hospital Anxiety and Depression Scale (HADS), we analyzed the correlation of anxiety and depression with steatorrhea, appetite, and weight loss in 72 patients with cancer of the esophagus or of the esophagogastric junction, who were treated at our rehabilitation clinic between January 2011 and December 2014. In addition, effectiveness of psychological interviews was analyzed.

Results: We have evaluable anxiety questionnaires from 51 patients showing a median anxiety value of 5 (range 0-13). As for the depression, results from evaluable questionnaires of 54 patients also showed a median value of 5 (range 0-15). Increased anxiety and depression values (> 7) were observed in 25.4% and 37.0% of the patients respectively. Patients who were admitted with steatorrhea for rehabilitation showed a statistically higher anxiety value (median 6.3 vs. 4.7, p < 0.05), reduced appetite, and a weight loss above 15 kg depicting a correlation to anxiety and depression. Psychological conversations helped lowering the depression but had no influence on anxiety.

Conclusions: Impairments after cancer treatment, such as steatorrhea, appetite loss, and weight loss, should be interpreted as an alarm signal and should necessitate screening for increased anxiety and depression. Psychological therapy can help improving the extent of the depression.

Citing Articles

Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients.

Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S Neuropsychiatr Dis Treat. 2019; 15:857-865.

PMID: 31118635 PMC: 6498985. DOI: 10.2147/NDT.S202432.

References
1.
Rutegard M, Charonis K, Lu Y, Lagergren P, Lagergren J, Rouvelas I . Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery. 2012; 152(5):903-10. DOI: 10.1016/j.surg.2012.03.025. View

2.
Dunn L, Aouizerat B, Cooper B, Dodd M, Lee K, West C . Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. Eur J Oncol Nurs. 2011; 16(1):1-9. PMC: 3115490. DOI: 10.1016/j.ejon.2011.01.003. View

3.
Derogar M, Orsini N, Sadr-Azodi O, Lagergren P . Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012; 30(14):1615-9. DOI: 10.1200/JCO.2011.40.3568. View

4.
Mitchell A, Meader N, Symonds P . Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord. 2010; 126(3):335-48. DOI: 10.1016/j.jad.2010.01.067. View

5.
McCorry N, Dempster M, Clarke C, Doyle R . Adjusting to life after esophagectomy: the experience of survivors and carers. Qual Health Res. 2009; 19(10):1485-94. DOI: 10.1177/1049732309348366. View